Peptide record

TPDB26065

Antibacterial Anticancer Toxicity modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26065
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 19-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
VDKPPYLPRPRPXRXXYNX
Physicochemical Analysis
C86H134N26O21
ACEQGHIMFSTW
P
1868.17
10.58
4
1
4
+3
4.95
-1.421
35.79
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
2980
159.51
3
Residue Composition
number
0
A
3
R
1
N
1
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
1
K
0
M
0
F
5
P
0
S
0
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 3 N: 1 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 5 S: 0 T: 0 W: 0 Y: 2 V: 1
Chemical Descriptors
19
C86H134N26O21
1868.17
10.58
+3
4.95
-1.421
Evidence Records 3 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex. | Chembiochem | 2011
Evidence 2 Activity

Activity

Toxicity
Hemolytic
NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex. | Chembiochem | 2011
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: Not active up to 600 µg/ml | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Chembiochem. 2011 Apr 11 12(6):874-6.